Biomaterials Market

Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2024

Report Code: BT 1556 Oct, 2019, by marketsandmarkets.com
Updated date -

[247 Pages Report] The biomaterials market is projected to reach USD 207 billion by 2024 from USD 105 billion in 2019, at a CAGR of 14.5% between 2019 and 2024. Factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases are driving the growth of the market. Emerging markets such as China, India, and Japan are the key areas of opportunity for players in this market. However, stringent clinical & regulatory processes and unfavorable healthcare reforms in the US are expected to restrain the growth of this market during the forecast period.

Biomaterials Market

To get more details on this report, Download PDF Brochure

Market Dynamics

Increased funds and grants by government bodies and universities for the development of novel biomaterials

The demand for and usage of biomaterials in various medical applications has increased significantly across the globe over the last few years. Also, several government bodies and universities have extended their help in the form of investments, funds, and grants to promote research into the development of novel biomaterials. Mentioned below are some of the important developments in this regard:

  • Two European Commission programs allocated USD 15.6 billion for biomaterials research for a period of five years (2013–2017).
  • In March 2018, Drexel University granted USD 200,000 to the National Science Foundation for research on how biomaterial-mediated control over macrophage behavior affects biomaterial vascularization.
  • In October 2016, researchers from the University of Strathclyde received a grant of USD 106,729 (EUR 98,848) from the Engineering and Physical Sciences Research Council (EPSRC) for engineering self-assembling silk hydrogels for the delivery of stem cells.
  • In January 2016, researchers from the University of Bolton received a grant of USD 107,805 (EUR 99,845) from EPSRC for the development of multifunctional gel scaffolds for cell delivery and tissue repair.
  • In October 2015, the Department of Defense (DoD) awarded USD 6 million to the Houston Methodist Research Institute (US) for studying two new materials that would help repair complex fractures in long bones.
  • In August 2015, the EPSRC granted USD 6.04 million (GBP 5.4 million) to Morgan Alexander (professor at the University of Nottingham) to support the Next Generation Biomaterials Discovery program.

Such research and funding activities are expected to boost the development of innovative biomaterials, thus offering an array of opportunities for the growth of the biomaterials market.

Stringent clinical & regulatory processes

Biomaterial-based medical devices are stringently regulated in several regions, including North America, Europe, and Asia, to ensure their quality and efficacy. This is primarily attributed to the fact that most biomaterial-based medical devices are implantable. All new biomaterials require proof that they are safe and effective before they can be approved for marketing. In the US, the process for approval follows strict guidelines and regulations set by the FDA. According to the FDA, biomaterial-based products such as implantable pacemakers, stents, and heart valves are classified as Class III devices, which pose the highest potential risk of illness or injury. Thus, these devices are subjected to the premarket approval application pathway (which is the most stringent type of device marketing application).

The development of biomaterials involves time-consuming processes and expensive clinical trials. As these products have to be implanted inside the human body, they need to be biocompatible and have to undergo the ISO biocompatibility testing standards. However, it is difficult to anticipate the biocompatibility until the later stages of clinical trials, making companies and investors apprehensive of investing in this market. In addition, regulatory procedures are complicated, restrictive, and depend on biomaterial composition and future application. These factors are expected to restrain market growth to a certain extent in the coming years.

Increasing number of free-trade agreements

Free-trade agreements (FTAs) comprise a treaty between two or more countries, aimed at reducing trade barriers such as tariffs and customs. These agreements are aimed at enabling rapid and smoother movement of goods across the member countries, improve market access, and enhance the economic relationship between the member countries. FTAs also enable the elimination of duties on trade goods, including pharmaceuticals and medical devices. As a result, FTAs offer major opportunities for medical device companies to increase their exports and expand their market reach in member countries. The recent implementations of several FTAs are thus expected to increase the demand for medical devices across the participating countries. A few of the agreements are listed below.

Shortage of skilled surgeons

According to the Lancet Commission on Global Surgery, ~2.2 million more surgeons, anesthetists, and obstetricians are required in low- and middle-income countries (LMICs) each year. Also, major healthcare markets such as the US, Germany, and the UK are witnessing a dearth of surgeons in their respective healthcare systems. For instance, according to the Association of American Medical Colleges, a deficit of 41,000 general surgeons is estimated in the US by 2025. Similarly, Ohio State University has projected that there would be about 3,000 cardiothoracic surgeons available to cover about 854,000 cases by 2030. Similarly, in the UK, there is 1 vascular surgeon per 137,000 individuals (Source: Survey conducted by the Vascular Society of Great Britain & Ireland in 2016).

The significant shortage of surgeons available to handle the increasing demand for procedures is expected to affect the uptake of implantable devices in the coming years. This is considered as a major challenge for the growth of the biomaterials market.

The metallic biomaterials dominated the biomaterials market in 2018

By type, the market is segmented into metallic, polymeric, ceramic, and natural biomaterials. The metallic biomaterials segment dominated the market in 2018. The dominant share of this segment is primarily attributed to the wide use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopedic applications. However, the polymeric biomaterials segment is expected to grow at the highest CAGR during the forecast period. This is mainly due to the increasing use of polymers in soft-tissue applications such as plastic surgeries.

Biomaterials Market

To get more details on this report, Request FREE Sample

The APAC market is expected to grow at the highest CAGR during the forecast period

North America dominated the market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period. Japan’s growing healthcare industry, rising geriatric population in China and India, and rising prevalence of cardiovascular diseases in India are some of the key factors driving the growth of the market in the Asia Pacific region.

Key Market Players

Prominent players in the market are Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).

Royal DSM offers coatings, drug delivery platforms, and a wide range of biomedical materials, such as bioceramics, biomedical polyethylenes, biomedical polyurethanes, collagens, and ophthalmic biomaterials for various applications, such as orthopedics, sports medicine, ophthalmology, general surgery, and cardiology. The company offers polyethylenes under the brand names—Dyneema Purity Woven, Dyneema Purity Black Fiber, Dyneema Purity Radiopaque Fiber, Dyneema Purity SGX Fiber, Dyneema Purity TG Fiber, Dyneema Purity UG / VG Fiber, and Dyneema Purity Membrane.

Scope of the Report:

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Type, Application, and Region

Geographies covered

North America, Europe, the Asia Pacific, and the Rest of the World

Companies covered

Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).

The research report categorizes the market into the following segments and subsegments:

Biomaterials Market, by Type

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Polymeric Biomaterials
  • Natural Biomaterials

Biomaterials Market, by Applications

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Neurology
  • Other Applications

Biomaterials Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World

Recent Developments

  • In July 2019, Royal DSM (Netherlands) entered into a partnership with ProMed Pharma (US). This partnership was aimed at developing novel sustained release drug delivery solutions in the polymeric drug delivery area.
  • In 2017, Royal DSM (Netherlands) launched Dyneema Purity Black Fiber.

Critical questions answered in the report:

  • How will the current technological trends affect the market in the long-term?
  • What are the reasons contributing to the growth of the polymeric market?
  • Which regions are likely to grow at the highest CAGR?
  • What are the challenges hindering the adoption of biomaterials?
  • What are the growth strategies being implemented by major market players?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 31)
    1.1 Objectives of Study
    1.2 Market Definition
           1.2.1 Markets Covered
                 Figure 1 Global Biomaterials Market Segmentation
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 35)
    2.1 Research Methodology Steps
        Figure 2 Research Methodology: Biomaterials Market
    2.2 Research Design
    2.3 Secondary Data
           2.3.1 Primary Data
                 Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
                    2.3.1.1 Key Data From Primary Sources
                    2.3.1.2 Key Industry Insights
    2.4 Market Size Estimation Methodology
        Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
        Figure 5 Market Size Estimation Methodology: Top-Down Approach
    2.5 Market Data Validation and Triangulation
        Figure 6 Data Triangulation Methodology
    2.6 Assumptions for the Study:

3 Executive Summary (Page No. - 44)
  Figure 7 Biomaterials Market, By Type, 2019 vs 2024 (USD Billion)
  Figure 8 Metallic Biomaterials Market, By Type, 2019 vs 2024 (USD Billion)
  Figure 9 Ceramic Biomaterials Market, By Type, 2019 vs 2024 (USD Billion)
  Figure 10 Polymeric Biomaterials Market, By Type, 2019 vs 2024 (USD Billion)
  Figure 11 Natural Biomaterials Market, By Type, 2019 vs 2024 (USD Billion)
  Figure 12 Plastic Surgery Segment to Grow at the Highest CAGR During the Forecast Period
  Figure 13 North America Accounted for the Largest Share of the Biomaterials Market

4 Premium Insights (Page No. - 50)
    4.1 Biomaterials Market Overview
        Figure 14 Increasing Demand for Implantable Devices to Drive the Growth of the Market
    4.2 Biomaterials Market, By Type, 2018 (USD Billion)
        Figure 15 Metallic Biomaterials to Dominate the North American Biomaterials Market During the Forecast Period
    4.3 Biomaterials Market: Geographic Snapshot
        Figure 16 Asia Pacific to Grow at the Highest CAGR During the Forecast Period

5 Market Overview (Page No. - 53)
    5.1 Introduction
    5.2 Market Dynamics
        Figure 17 Biomaterials Market: Drivers, Restraints, Opportunities, and Challenges
           5.2.1 Drivers
                    5.2.1.1 Increased Funds and Grants By Government Bodies and Universities for the Development of Novel Biomaterials
                    5.2.1.2 Increasing Demand for Implantable Devices
                    5.2.1.3 Growing Demand for Biomaterials in Plastic Surgery and Wound Healing Applications
                    5.2.1.4 Rising Incidence of Cardiovascular Diseases
                    5.2.1.5 Increasing Research on Regenerative Medicine
           5.2.2 Restraints
                    5.2.2.1 Stringent Clinical & Regulatory Processes
                    5.2.2.2 Unfavorable Healthcare Reforms in the Us
           5.2.3 Opportunities
                    5.2.3.1 Growing Healthcare Market in Emerging Economies
                    5.2.3.2 Increasing Number of Free-Trade Agreements
           5.2.4 Challenges
                    5.2.4.1 Limitations of Biomaterial-Based Products
                    5.2.4.2 Shortage of Skilled Surgeons

6 Regulatory Assessment (Page No. - 60)
    6.1 Introduction
    6.2 US
           6.2.1 Introduction
           6.2.2 FDA Device Classification
                 Figure 18 US: Regulatory Approval Process
           6.2.3 US: Regulatory Approval Timeline Assessment
                 Figure 19 Regulatory Approval Timeline in the US
           6.2.4 Stringent FDA Regulations Governing Product Approvals
    6.3 Canada
           6.3.1 Introduction
           Figure 20 Canada: Regulatory Approval Process
           6.3.2 Canada: Regulatory Approval Timeline Assessment
           Figure 21 Regulatory Approval Timeline in Canada
           6.3.3 Health Canada Classification
    6.4 Europe
           6.4.1 Introduction
           6.4.2 European Medical Device Classification
           Figure 22 Europe: Regulatory Approval Process
           6.4.3 Europe: Regulatory Approval Timeline Assessment
           Figure 23 Regulatory Approval Timeline in Europe
           6.4.4 European Regulatory Process to Get More Stringent in Future
    6.5 Japan
           6.5.1 Introduction
           6.5.2 PMDa Device Classification
           Figure 24 Japan: Regulatory Approval Process
           6.5.3 Japan: Regulatory Approval Timeline Assessment
           Figure 25 Regulatory Approval Timeline in Japan
           6.5.4 Revision of the Pharmaceutical Affairs Law (PAL) and Implementation of the New PMD Act in Japan
    6.6 China
           6.6.1 Introduction
           6.6.2 Cfda Device Classification
           Figure 26 China: Regulatory Approval Process
           6.6.3 China: Regulatory Approval Timeline Assessment
           Figure 27 Regulatory Approval Timeline in China
           6.6.4 Rising Hurdles in the Regulatory Process in China
    6.7 India
           6.7.1 Introduction
           Figure 28 India: Regulatory Approval Process
           6.7.2 Indian Medical Devices Classification
    6.8 Australia
           6.8.1 Introduction
           6.8.2 Tga Device Classification
           Figure 29 Australia: Regulatory Approval Process
           6.8.3 Australia: Regulatory Approval Timeline Assessment
           Figure 30 Regulatory Approval Timeline in Australia

7 Biomaterials Market, By Type (Page No. - 82)
    7.1 Introduction
        Table 1 Important Properties of Biomaterials, By Application
        Table 2 Biomaterials Market, By Type, 2017–2024 (USD Billion)
        Figure 31 Polymeric Biomaterials to Grow at the Highest CAGR During the Forecast Period
    7.2 Metallic Biomaterials
        Figure 32 Titanium and Titanium Alloys Segment to Grow at the Highest CAGR During the Forecast Period
        Table 3 Metallic Biomaterials Market, By Type, 2017–2024 (USD Billion)
        Table 4 Metallic Biomaterials Market, By Region, 2017–2024 (USD Billion)
           7.2.1 Stainless Steel
                    7.2.1.1 Stainless Steel Dominates the Metallic Biomaterials Market
                            Table 5 Stainless Steel Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.2.2 Titanium & Titanium Alloys
                    7.2.2.1 Rising Number of Joint Replacement Procedures Will Drive the Market for Titanium Biomaterials
                            Table 6 Titanium & Titanium Alloy Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.2.3 Cobalt-Chrome Alloys
                    7.2.3.1 Low Cost and Excellent Corrosion Resistance have Driven the Use of Cobalt-Chrome Alloys
                            Table 7 Cobalt-Chrome Alloy Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.2.4 Gold
                    7.2.4.1 Expanding Applications of Gold Nanoparticles to Drive the Demand for Gold Biomaterials
                            Table 8 Gold Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.2.5 Silver
                    7.2.5.1 Toxic Properties and Low Aesthetic Appeal Likely to Limit the Use of Silver in Biomaterial-Based Products
                            Table 9 Silver Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.2.6 Magnesium
                    7.2.6.1 Biodegradable Characteristic of Magnesium have Stimulated the Growth of This Market Segment
                            Table 10 Magnesium Biomaterials Market, By Region, 2017–2024 (USD Million)
    7.3 Polymeric Biomaterials
        Table 11 Applications of Synthetic Polymers
        Table 12 Polymeric Biomaterials Market, By Type, 2017–2024 (USD Billion)
        Figure 33 Pmma Segment to Grow at the Highest CAGR During the Forecast Period
        Table 13 Polymeric Biomaterials Market, By Region, 2017–2024 (USD Billion)
           7.3.1 Polymethylmethacrylate
                    7.3.1.1 Pmma Dominates the Polymeric Biomaterials Market
                            Table 14 Polymethylmethacrylate Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.3.2 Polyethylene
                    7.3.2.1 Wear and Tear Resistance of Polyethylene have Made It Popular in Hip and Knee Joint Replacements
                            Table 15 Polyethylene Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.3.3 Polyester
                    7.3.3.1 Biodegradable Nature and Biocompatibility of Polyester Will Drive Its Use in Various Medical Applications
                            Table 16 Polyester Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.3.4 Polyvinylchloride
                    7.3.4.1 Heavy Chlorine Content of Pvc is Likely to Hamper the Market Growth
                            Table 17 Polyvinylchloride Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.3.5 Silicone Rubber
                    7.3.5.1 Silicone Rubbers are Non-Reactive, Stable, and Resistant to Extreme Environments and Temperatures
                            Table 18 Silicone Rubber Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.3.6 Nylon
                    7.3.6.1 Nylon’s Low Weight, Corrosion Resistance, and Wide Applications are Expected to Drive Market Demand
                            Table 19 Nylon Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.3.7 Polyetheretherketone
                    7.3.7.1 Peek is Gaining Popularity as A Viable Alternative to Metals
                            Table 20 Polyetheretherketone Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.3.8 Other Polymeric Biomaterials
                 Table 21 Other Polymeric Biomaterials Market, By Region, 2017–2024 (USD Million)
    7.4 Ceramics
        Figure 34 Ceramic Biomaterials Market, By Type, 2017 vs 2024
        Table 22 Ceramic Biomaterials Market, By Type, 2017–2024 (USD Billion)
        Table 23 Ceramic Biomaterials Market, By Region, 2017–2024 (USD Billion)
           7.4.1 Calcium Phosphate
                    7.4.1.1 Calcium Phosphate Drives Ceramic Biomaterial Market Segment
                            Table 24 Calcium Phosphate Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.4.2 Zirconia
                    7.4.2.1 Bio-Inertness and Low Wear Rate of Zirconia Will Boost the Market Growth
                            Table 25 Zirconia Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.4.3 Aluminum Oxide
                    7.4.3.1 Increasing Use of Aluminum Oxide in Hip Replacements and Dental Implants to Drive the Market
                            Table 26 Aluminum Oxide Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.4.4 Calcium Sulfate
                    7.4.4.1 Fast Resorption Rate of Calcium Sulfate is Likely to Hamper Its Use
                            Table 27 Calcium Sulfate Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.4.5 Carbon
                    7.4.5.1 Increasing Use of Carbon Nanofibers in Regenerative Medicine and Cancer Treatment Will Drive Market Growth
                            Table 28 Carbon Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.4.6 Glass
                    7.4.6.1 Rising Number of Orthopedics and Dental Procedures Likely to Drive the Demand for Glass Biomaterials
                            Table 29 Glass Biomaterials Market, By Region, 2017–2024 (USD Million)
    7.5 Natural Biomaterials
        Table 30 Applications of Natural Biomaterials
        Table 31 Natural Biomaterials Market, By Type, 2017–2024 (USD Billion)
        Figure 35 Hyaluronic Acid Segment to Grow at the Highest CAGR During the Forecast Period
        Table 32 Natural Biomaterials Market, By Region, 2017–2024 (USD Billion)
           7.5.1 Hyaluronic Acid
                    7.5.1.1 Rising Prevalence of Osteoarthritis to Drive Hyaluronic Acid Market
                            Table 33 Hyaluronic Acid Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.5.2 Collagen
                    7.5.2.1 Rising Prevalence of Target Applications to Drive Growth in Collagen Market
                            Table 34 Collagen Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.5.3 Gelatin
                    7.5.3.1 Low Cost of Gelatin to Drive Its Market Growth
                            Table 35 Gelatin Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.5.4 Fibrin
                    7.5.4.1 Fibrin Biomaterials Were Among the First Used to Prevent Bleeding
                            Table 36 Fibrin Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.5.5 Cellulose
                    7.5.5.1 Cellulose Find Applications in Wound Healing, Skin Regeneration, and Ophthalmology
                            Table 37 Cellulose Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.5.6 Chitin
                    7.5.6.1 Chitin Accelerates Skin Regeneration and Possesses High Biocompatibility
                            Table 38 Chitin Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.5.7 Alginates
                    7.5.7.1 Various Applications of Alginates Include Wound Healing, Tissue Engineering & Regenerative Medicine, and Drug Delivery
                            Table 39 Alginate Biomaterials Market, By Region, 2017–2024 (USD Million)
           7.5.8 Silk
                    7.5.8.1 The Flexibility, Glossiness, and Adhesive Abilities of Silk have Made It Popular in Cosmetic Applications
                            Table 40 Silk Biomaterials Market, By Region, 2017–2024 (USD Million)

8 Biomaterials Market, By Application (Page No. - 112)
    8.1 Introduction
        Table 41 Biomaterials Market, By Application, 2017–2024 (USD Billion)
        Figure 36 Plastic Surgery Segment to Register the Highest CAGR During the Forecast Period
    8.2 Cardiovascular
        Table 42 Biomaterials Market for Cardiovascular Applications, By Product, 2017–2024 (USD Billion)
        Table 43 Biomaterials Market for Cardiovascular Applications, By Region, 2017–2024 (USD Billion)
        Figure 37 Stents Segment to Register the Highest CAGR During The Forecast Period
           8.2.1 Catheters
                 Table 44 Biomaterials Market for Catheters, By Region, 2017–2024 (USD Billion)
           8.2.2 Stents
                 Table 45 Biomaterials Market for Stents, By Region, 2017–2024 (USD Billion)
           8.2.3 Implantable Cardiac Defibrillators
                 Table 46 Biomaterials Market for Implantable Cardiac Defibrillators, By Region, 2017–2024 (USD Billion)
           8.2.4 Pacemakers
                 Table 47 Biomaterials Market for Pacemakers, By Region, 2017–2024(USD Billion)
           8.2.5 Sensors
                 Table 48 Biomaterials Market for Sensors, By Region, 2017–2024 (USD Billion)
           8.2.6 Heart Valves
                 Table 49 Biomaterials Used for Different Valve Components
                 Table 50 Biomaterials Market for Heart Valves, By Region, 2017–2024 (USD Billion)
           8.2.7 Vascular Grafts
                 Table 51 Biomaterials Market for Vascular Grafts, By Region, 2017–2024 (USD Billion)
           8.2.8 Guidewires
                 Table 52 Biomaterials Market for Guidewires, By Region, 2017–2024(USD Billion)
           8.2.9 Others
                 Table 53 Biomaterials Market for Other Cardiovascular Applications, By Region, 2017–2024 (USD Billion)
    8.3 Orthopedic
                 Figure 38 Joint Replacement to Dominate the Orthopedic Biomaterials Market During the Forecast Period
                 Table 54 Biomaterials Market for Orthopedic Applications, By Type, 2017–2024 (USD Billion)
                 Table 55 Biomaterials Market for Orthopedic Applications, By Region, 2017–2024 (USD Billion)
           8.3.1 Joint Replacement
                 Table 56 Joint Replacement Biomaterials Market, By Type, 2017–2024 (USD Billion)
                 Table 57 Joint Replacement Biomaterials Market, By Region, 2017–2024 (USD Billion)
                    8.3.1.1 Knee Replacement
                            Table 58 Knee Replacement Biomaterials Market, By Region, 2017–2024 (USD Million)
                    8.3.1.2 Hip Replacement
                            Table 59 Hip Replacement Biomaterials Market, By Region, 2017–2024 (USD Million)
                    8.3.1.3 Shoulder Replacement
                            Table 60 Shoulder Replacement Biomaterials Market, By Region, 2017–2024 (USD Million)
                    8.3.1.4 Others
                            Table 61 Other Joint Replacement Biomaterials Market, By Region, 2017–2024 (USD Million)
           8.3.2 Viscosupplementation
                 Table 62 Viscosupplementation Biomaterials Market, By Region, 2017–2024 (USD Million)
           8.3.3 Bioresorbable Tissue Fixation
                 Table 63 Bioresorbable Biomaterials Market, By Product, 2017–2024 (USD Billion)
                 Table 64 Bioresorbable Biomaterials Market, By Region, 2017–2024 (USD Billion)
                    8.3.3.1 Suture Anchors
                            Table 65 Biomaterials Market for Suture Anchors, By Region, 2017–2024(USD Million)
                    8.3.3.2 Interference Screws
                            Table 66 Biomaterials Market for Interference Screws, By Region, 2017–2024 (USD Million)
                    8.3.3.3 Meniscal Repair Tacks
                            Table 67 Biomaterials Market for Meniscal Repair Tacks, By Region, 2017–2024(USD Million)
                    8.3.3.4 Meshes
                            Table 68 Biomaterials Market for Meshes, By Region, 2017–2024(USD Million)
           8.3.4 Spine
                 Table 69 Biomaterials Market for Spine Surgeries, By Type, 2017–2024 (USD Billion)
                 Table 70 Biomaterials Market for Spine Surgeries, By Region, 2017–2024 (USD Billion)
                    8.3.4.1 Spinal Fusion Surgeries
                            Table 71 Biomaterials Market for Spinal Fusion Surgeries, By Region, 2017–2024 (USD Million)
                    8.3.4.2 Minimally Invasive Fusion Surgeries
                            Table 72 Biomaterials Market for Minimally Invasive Fusion Surgeries, By Region, 2017–2024 (USD Million)
                    8.3.4.3 Motion Preservation & Dynamic Stabilization Surgeries
                            Table 73 Biomaterials Market for Motion Preservation & Dynamic Stabilization Surgeries, By Product, 2017–2024 (USD Million)
                            Table 74 Biomaterials Market for Motion Preservation & Dynamic Stabilization Surgeries, By Region, 2017–2024 (USD Million)
                               8.3.4.3.1 Pedicle-Based Rod Systems
                                         Table 75 Biomaterials Market for Pedicle-Based Rod Systems, By Region, 2017–2024 (USD Million)
                               8.3.4.3.2 Interspinous Spacers
                                         Table 76 Biomaterials Market for Interspinous Spacers, By Region, 2017–2024 (USD Million)
                               8.3.4.3.3 Artificial Discs
                                         Table 77 Biomaterials Market for Artificial Discs, By Region, 2017–2024 (USD Million)
           8.3.5 Fracture Fixation Devices
                 Table 78 Biomaterials Market for Fracture Fixation Devices, By Type, 2017–2024 (USD Billion)
                 Table 79 Biomaterials Market for Fracture Fixation Devices, By Region, 2017–2024 (USD Billion)
                    8.3.5.1 Bone Plates
                            Table 80 Biomaterials Market for Bone Plates, By Region, 2017–2024 (USD Million)
                    8.3.5.2 Screws
                            Table 81 Biomaterials Market for Screws, By Region, 2017–2024 (USD Million)
                    8.3.5.3 Pins
                            Table 82 Biomaterials Market for Pins, By Region, 2017–2024 (USD Million)
                    8.3.5.4 Rods
                            Table 83 Biomaterials Market for Rods, By Region, 2017–2024 (USD Million)
                    8.3.5.5 Wires
                            Table 84 Biomaterials Market for Wires, By Region, 2017–2024 (USD Million)
           8.3.6 Synthetics Bone Grafts
                 Table 85 Biomaterials Market for Synthetic Bone Grafts, By Region, 2017–2024 (USD Million)
    8.4 Ophthalmology
           8.4.1 Increasing Prevalence of Eye Diseases to Drive Market Growth
                 Table 86 Biomaterials Market for Ophthalmology Applications, By Type, 2017–2024 (USD Billion)
                 Table 87 Biomaterials Market for Ophthalmology Applications, By Region, 2017–2024 (USD Billion)
                 Figure 39 Contact Lenses Segment to Dominate the Biomaterials Market for Ophthalmology Applications During the Forecast Period
           8.4.2 Contact Lenses
                 Table 88 Biomaterials Market for Contact Lenses, By Region, 2017–2024 (USD Billion)
           8.4.3 Intraocular Lenses
                 Table 89 Biomaterials Market for Intraocular Lenses, By Region, 2017–2024 (USD Million)
           8.4.4 Functional Replacement of Ocular Tissues
                 Table 90 Biomaterials Market for Functional Replacement of Ocular Tissues, By Region, 2017–2024 (USD Million)
           8.4.5 Synthetic Corneas
                 Table 91 Biomaterials Market for Synthetic Corneas, By Region, 2017–2024 (USD Million)
           8.4.6 Others
                 Table 92 Biomaterials Market for Other Ophthalmology Applications, By Region, 2017–2024 (USD Million)
    8.5 Dental
           8.5.1 Synthetic Dental Biomaterials Include Metals, Ceramics, Polymers, and Composite Structures
                 Table 93 Biomaterials Market for Dental Applications, By Product, 2017–2024 (USD Billion)
                 Table 94 Biomaterials Market for Dental Applications, By Region, 2017–2024 (USD Billion)
                 Figure 40 Dental Implants Segment to Witness the Highest Growth in the Dental Biomaterials Market During the Forecast Period
           8.5.2 Dental Implants
                 Table 95 Percentage of Individuals With Untreated Dental Caries in the US (2016)
                 Table 96 Biomaterials Market for Dental Implants, By Region, 2017–2024 (USD Billion)
           8.5.3 Dental Bone Grafts & Substitutes
                 Table 97 Biomaterials Market for Dental Bone Grafts & Substitutes, By Region, 2017–2024 (USD Million)
           8.5.4 Dental Membranes
                 Table 98 Biomaterials Market for Dental Membranes, By Region, 2017–2024 (USD Million)
           8.5.5 Tissue Regeneration
                 Table 99 Biomaterials Market for Tissue Regeneration, By Region, 2017–2024 (USD Million)
    8.6 Plastic Surgery
           8.6.1 Growing Number of Cosmetic Surgeries Performed to Drive the Market for Biomaterials
                 Table 100 Biomaterials Market for Plastic Surgery, By Application, 2017–2024 (USD Billion)
                 Table 101 Biomaterials Market for Plastic Surgery, By Region, 2017–2024 (USD Billion)
                 Figure 41 Soft-Tissue Fillers Segment Will Continue to Dominate the Biomaterials Market for Plastic Surgery in 2024
           8.6.2 Soft-Tissue Fillers
                 Table 102 Biomaterials Market for Soft-Tissue Fillers, By Region, 2017–2024 (USD Million)
           8.6.3 Craniofacial Surgery
                 Table 103 Biomaterials Market for Craniofacial Surgery, By Region, 2017–2024 (USD Billion)
    8.7 Wound Healing
           8.7.1 Biomaterials are Extensively Used in Various Wound Healing Products
                 Table 104 Biomaterials Market for Wound Healing Applications, By Product, 2017–2024 (USD Billion)
                 Table 105 Biomaterials Market for Wound Healing Applications, By Region, 2017–2024 (USD Billion)
                 Figure 42 Internal Tissue Sealants Segment to Register the Highest CAGR During the Forecast Period
           8.7.2 Wound Closure Devices
                 Table 106 Biomaterials Market for Wound Closure Devices, By Product, 2017–2024 (USD Million)
                 Table 107 Biomaterials Market for Wound Closure Devices, By Region, 2017–2024 (USD Million)
                    8.7.2.1 Sutures
                            Table 108 Biomaterials Market for Sutures, By Region, 2017–2024 (USD Million)
                    8.7.2.2 Staples
                            Table 109 Biomaterials Market for Staples, By Region, 2017–2024 (USD Million)
           8.7.3 Surgical Hemostats
                 Table 110 Biomaterials Market for Surgical Hemostats, By Region, 2017–2024 (USD Million)
           8.7.4 Internal Tissue Sealants
                 Table 111 Biomaterials Market for Internal Tissue Sealants, By Region, 2017–2024 (USD Million)
           8.7.5 Adhesion Barriers
                 Table 112 Biomaterials Market for Adhesion Barriers, By Region, 2017–2024 (USD Million)
           8.7.6 Hernia Meshes
                 Table 113 Biomaterials Market for Hernia Meshes, By Region, 2017–2024 (USD Million)
    8.8 Tissue Engineering
           8.8.1 Increasing Demand for Enhanced Mechanical Performance of Tissue-Engineered Implants to Support the Growth of This Application Segment
                 Table 114 Tissue Engineering Biomaterials Market, By Application, 2017–2024 (USD Billion)
                 Table 115 Tissue Engineering Biomaterials Market, By Region, 2017–2024 (USD Billion)
                 Figure 43 Scaffolds for Regenerative Medicine Segment to Dominate the Tissue Engineering Biomaterials Market in 2018
           8.8.2 Scaffolds for Regenerative Medicine
                 Table 116 Tissue Engineering Biomaterials Market for Scaffolds for Regenerative Medicine, By Region, 2017–2024 (USD Million)
           8.8.3 Nanomaterials for Biosensing
                 Table 117 Tissue Engineering Biomaterials Market for Nanomaterials for Biosensing, By Region, 2017–2024 (USD Million)
           8.8.4 Tailoring of Inorganic Nanoparticles
                 Table 118 Tissue Engineering Biomaterials Market for Tailoring of Inorganic Nanoparticles, By Region, 2017–2024 (USD Million)
    8.9 Neurological/Central Nervous System Applications
           8.9.1 The Major Application Areas of Biomaterials in CNS Disorders Include Shunting, Cortical Neural Prosthesis, and Neural Stem Cell Encapsulation
                 Table 119 Biomaterials Market for Neurological/CNS Applications, By Product, 2017–2024 (USD Million)
                 Table 120 Biomaterials Market for Neurological/CNS Applications, By Region, 2017–2024 (USD Million)
                 Figure 44 Cortical Neural Prosthetics Segment to Register the Highest CAGR During the Forecast Period
           8.9.2 Shunting Systems
                 Table 121 Biomaterials Market for Shunting Systems, By Region, 2017–2024 (USD Million)
           8.9.3 Cortical Neural Prosthetics
                 Table 122 Biomaterials Market for Cortical Neural Prosthetics, By Region, 2017–2024 (USD Million)
           8.9.4 Hydrogel Scaffolds for CNS Repair
                 Table 123 Biomaterials Market for Hydrogel Scaffolds for CNS Repair, By Region, 2017–2024 (USD Million)
           8.9.5 Neural Stem Cell Encapsulation
                 Table 124 Biomaterials Market for Neural Stem Cell Encapsulation, By Region, 2017–2024 (USD Million)
    8.10 Other Applications
         Table 125 Other Biomaterial Applications Market, By Type, 2017–2024 (USD Million)
                  Table 126 Other Biomaterial Applications Market, By Region, 2017–2024 (USD Million)
           8.10.1 Drug Delivery Systems
                  Table 127 Biomaterials Market for Drug Delivery Systems, By Region, 2017–2024 (USD Million)
           8.10.2 Gastrointestinal Applications
                  Table 128 Biomaterials Market for Gastrointestinal Applications, By Region, 2017–2024 (USD Million)
           8.10.3 Bariatric Surgery
                  Table 129 Biomaterials Market for Bariatric Surgery, By Region, 2017–2024 (USD Million)
           8.10.4 Urinary Applications
                  Table 130 Biomaterials Market for Urinary Applications, By Region, 2017–2024 (USD Million)

9 Biomaterials Market, By Region (Page No. - 175)
    9.1 Introduction
        Table 131 Biomaterials Market, By Region, 2017–2024 (USD Billion)
        Figure 45 Biomaterials Market, By Region, 2019 vs 2024 (USD Billion)
    9.2 North America
        Figure 46 North America: Biomaterials Market Snapshot
        Table 132 North America: Biomaterials Market, By Country, 2017–2024 (USD Billion)
        Table 133 North America: Biomaterials Market, By Type, 2017–2024 (USD Billion)
        Table 134 North America: Biomaterials Market, By Application, 2017–2024 (USD Billion)
           9.2.1 US
                    9.2.1.1 US Dominates the North American Biomaterials Market
                            Table 135 US: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                            Table 136 US: Biomaterials Market, By Application, 2017–2024 (USD Billion)
           9.2.2 Canada
                    9.2.2.1 Increasing Incidence of Cardiovascular Diseases to Drive Market Growth in Canada
                            Table 137 Canada: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                            Table 138 Canada: Biomaterials Market, By Application, 2017–2024 (USD Million)
    9.3 Europe
        Figure 47 Europe: Biomaterials Market Snapshot
        Table 139 Europe: Biomaterials Market, By Country, 2017–2024 (USD Billion)
        Table 140 Europe: Biomaterials Market, By Type, 2017–2024 (USD Billion)
        Table 141 Europe: Biomaterials Market, By Application, 2017–2024 (USD Billion)
           9.3.1 Germany
                    9.3.1.1 Large Medical Devices Market to Support the Adoption of Biomaterials in Germany
                            Table 142 Germany: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                            Table 143 Germany: Biomaterials Market, By Application, 2017–2024 (USD Billion)
           9.3.2 UK
                    9.3.2.1 Availability of Funds and Rising Cardiovascular Procedures to Drive the Biomaterials Market in the UK
                            Table 144 UK: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                            Table 145 UK: Biomaterials Market, By Application, 2017–2024 (USD Billion)
           9.3.3 France
                    9.3.3.1 Rising Aging Population and Associated Diseases to Drive the Market in France
                            Table 146 France: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                            Table 147 France: Biomaterials Market, By Application, 2017–2024 (USD Billion)
           9.3.4 Spain
                    9.3.4.1 Increasing Research Activities on Biomaterials to Drive the Growth in Spain
                            Table 148 Spain: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                            Table 149 Spain: Biomaterials Market, By Application, 2017–2024 (USD Million)
           9.3.5 Rest of Europe (RoE)
                 Table 150 RoE: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                 Table 151 RoE: Biomaterials Market, By Application, 2017–2024 (USD Million)
    9.4 Asia Pacific
        Figure 48 Asia Pacific: Biomaterials Market Snapshot
        Table 152 APAC: Biomaterials Market, By Country/Region, 2017–2024 (USD Billion)
        Table 153 APAC: Biomaterials Market, By Type, 2017–2024 (USD Billion)
        Table 154 APAC: Biomaterials Market, By Application, 2017–2024 (USD Billion)
           9.4.1 Japan
                    9.4.1.1 Growing Medical Devices Industry to Drive Market Growth
                            Table 155 Japan: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                            Table 156 Japan: Biomaterials Market, By Application, 2017–2024 (USD Billion)
           9.4.2 China
                    9.4.2.1 Lucrative Medical Devices Industry in China
                            Table 157 China: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                            Table 158 China: Biomaterials Market, By Application, 2017–2024 (USD Billion)
           9.4.3 India
                    9.4.3.1 Large Population Base and Growing Medical Tourism in India to Drive the Growth of Biomaterials
                            Table 159 India: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                            Table 160 India: Biomaterials Market, By Application, 2017–2024 (USD Million)
           9.4.4 Rest of Asia Pacific (RoAPAC)
                 Table 161 RoAPAC: Biomaterials Market, By Type, 2017–2024 (USD Billion)
                 Table 162 RoAPAC: Biomaterials Market, By Application, 2017–2024 (USD Million)
    9.5 Rest of the World (RoW)
        Figure 49 RoW: Biomaterials Market Snapshot
        Table 163 RoW: Biomaterials Market, By Type, 2017–2024 (USD Billion)
        Table 164 RoW: Biomaterials Market, By Application, 2017–2024 (USD Billion)

10 Competitive Landscape (Page No. - 205)
     10.1 Overview
     10.2 Competitive Scenario
          Figure 50 Key Growth Strategies Adopted By Market Players
          Table 165 Partnerships, Agreements, and Collaborations, By Companies (2015–2019)
             10.2.1 Product Launches
                    Table 166 Product Launches By Companies (2015–2019)
             10.2.2 Mergers and Acquisitions
                    Table 167 Merger and Acquisitions By Companies (2015–2018)
             10.2.3 Expansions
                    Table 168 Expansions By Companies (2015–2019)
     10.3 Competitive Leadership Mapping (Overall Market) (2018)
             10.3.1 Visionary Leaders
             10.3.2 Innovators
             10.3.3 Dynamic Differentiators
             10.3.4 Emerging Companies
                    Figure 51 Competitive Leadership Mapping: Biomaterials Market
     10.4 Competitive Leadership Mapping (Start-Up) (2018)
             10.4.1 Progressive Companies
             10.4.2 Starting Blocks
             10.4.3 Dynamic Companies
             10.4.4 Responsive Companies
                    Figure 52 Competitive Leadership Mapping: Biomaterials Market

11 Company Profiles (Page No. - 211)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     11.1 Royal DSM
          Figure 53 Royal DSM: Company Snapshot
     11.2 BASF SE
          Figure 54 BASF: Company Snapshot
     11.3 Corbion
          Figure 55 Corbion: Company Snapshot
     11.4 Covestro AG
          Figure 56 Covestro: Company Snapshot
     11.5 Carpenter Technology Corporation
          Figure 57 Carpenter Technology: Company Snapshot
     11.6 Evonik Industries
          Figure 58 Evonik Industries: Company Snapshot
     11.7 Berkeley Advanced Biomaterials, Inc.
     11.8 Cam Bioceramics B.V.
     11.9 Celanese Corporation
          Figure 59 Celanese Corporation: Company Snapshot
     11.10 Coorstek Inc.
     11.11 Ceramtec GmbH
           Figure 60 Ceramtec: Company Snapshot
     11.12 Gelita AG

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 235)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details

To get more details on this report, Request FREE Sample

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the market. The primary sources from the demand side included industry experts, such as researchers and scientists, and industry experts from medical devices companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Biomaterials Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, application, end user, and region).

Data Triangulation

After arriving at the market size, the market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments.

Objectives of the Study

  • To define, describe, segment, and forecast the market by type, application, and region.
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market in four main regions along with their respective key countries (North America, Europe, the Asia Pacific, and the Rest of the World)
  • To profile key players in the market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as product launches, expansions, and R&D activities of the leading players in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • A further breakdown of the Rest of Asia Pacific market into South Korea, New Zealand, and other South East Asian countries
  • A further breakdown of the European market into Italy, Belgium, Netherlands, Sweden, and the Rest of Europe.
Report Code
BT 1556
Published ON
Oct, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biomaterials Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home